Biotech China 2014
Innovations & Investments in Healthcare
Hotel Adlon Kempinski
Unter den Linden 77, 10117 Berlin, Germany
Berlin, Germany
http://www.amiando.com/IIHC2012.html
IIHC 2012 is where the most creative innovators meet investors in healthcare as well as representatives of well established healthcare enterprises. Regulators and payors will give an indication of what they will need and reimburse in the future.

Attend the conference at the the Hotel Adlon Kempinski and
    â–ª    find different paths into the future of healthcare
    â–ª    understand how developments like mobile health, lean healthcare and patient self management can drive change
    â–ª    gain valuable insights for your company and meet your cooperation partners of tomorrow
    â–ª    understand what payors will be asking from innovators
    â–ª    get the best networking opportunitites with leading innovators, investors and industry players

The conference has a strong focus on personal networking, discussions and the exchange of experience across sectoral and national borders. 
A limited number of discounted admissions for government agencies, start-ups and not-for-profit organizations are available. Please contact us at office(at)advisorsinhealthcare.com

The "Innovations & Investments in Healthcare" conference program is subject to changes. Roman Rittweger Advisors in Healthcare GmbH reserves the right to modify the program, which is published as an indication only, as amendments to the content and/or speakers may be necessary. Any substitutions or alterations will be updated on tthis website as soon as possible. Please understand that the participation fee cannot be refunded in case the participant cannot attend the conference for any reason. However, we will be pleased to accept a substitute participant at no additional cost.

http://www.amiando.com/IIHC2012.html

Schedule of Presentations:

Thursday, April 26, 2012
13:00:00 Registration opens
13:05:00 Lunch Buffet and Networking Coffee
14:30:00 Opening Address
14:45:00 Why are investments in healthcare so difficult? What needs to be done?
15:00:00 How to solve tomorrow's challenges with tomorrow's technologies Brian David Johnson
15:30:00 Networking Coffee
16:00:00 The new new things | Mobile health and social media in healthcare: What are the future opportunities and challenges in sharing and managing information? Christian Angele
16:45:00 Short Coffee Break
17:00:00 1 on 1 - 5 rounds of speed dating
18:30:00 Cocktail - Flying Buffet
Friday, April 27, 2012
08:30:00 Networking Breakfast
09:30:00 Current examples for Innovations & Investments: Different paths taken and different paths leading into the future Michael Nerlich, Rene R. Kuijten, Jonathan Javitt, Finn Goldner
10:30:00 Coffee Break
11:00:00 Future Demands on Public Healthcare: What regulators require and how innovation could work Halle Tecco, Sophia Schlette, Robert Jarrin, Bart Collet
12:00:00 Networking Lunch
13:15:00 3-Slide Presentations & Discussion with Expert Jury: Next steps into the future of healthcare Halle Tecco, Michael Nerlich, Brian David Johnson, Frank Antwerpes
13:20:00 1.) Quantified Self - Live Longer and Feel Better Know your data, know your genes and impact your health.
13:45:00 2.) Patient Self Management What can payors, providers and the industry do?
14:15:00 3.) Healthcare in the Information Age, Health 2.0, connectivity or new data analytics - what does it take to start the revolution? Claire Novorol
14:35:00 4.) Lean Healthcare New models of healthcare delivery - can they change the old paradigms? Joe Ryan, Hartwig Jaeger
14:45:00 5.) Corporate Investments and Venturing in Healthcare What drives investments in healthcare and what pharma and medtech companies can learn from a venture capital fund Chandra P. Leo
15:00:00 Open Space Feedback & Future Outlook: Tell the audience your wishes and suggestions for the future.
15:30:00 Networking Coffee & Goodbye
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.